Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
38,343,239
-
Share change
-
-1,534,077
-
Total reported value
-
$3,061,975,208
-
Put/Call ratio
-
413%
-
Price per share
-
$79.84
-
Number of holders
-
227
-
Value change
-
-$120,732,380
-
Number of buys
-
115
-
Number of sells
-
133
Institutional Holders of CANTEL MEDICAL CORP - COM (CMD) as of Q1 2021
As of 31 Mar 2021,
CANTEL MEDICAL CORP - COM (CMD) was held by
227 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
38,343,239 shares.
The largest 10 holders included
BlackRock Inc., Champlain Investment Partners, LLC, VANGUARD GROUP INC, JPMORGAN CHASE & CO, Leonard Green & Partners, L.P., STATE STREET CORP, DIKER MANAGEMENT LLC, CITADEL ADVISORS LLC, CREDIT SUISSE AG/, and BROWN CAPITAL MANAGEMENT LLC.
This page lists
227
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.